Shin Nippon Biomedical Laboratories 将来の成長
Future 基準チェック /36
Shin Nippon Biomedical Laboratories利益と収益がそれぞれ年間9.7%と7.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に12.1% 12.5%なると予測されています。
主要情報
9.7%
収益成長率
12.5%
EPS成長率
| Life Sciences 収益成長 | 27.1% |
| 収益成長率 | 7.3% |
| 将来の株主資本利益率 | 12.1% |
| アナリストカバレッジ | Low |
| 最終更新日 | 20 Nov 2024 |
今後の成長に関する最新情報
Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts
Aug 09
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 10Recent updates
What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You
Nov 25Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Sep 19Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts
Aug 09Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding
Aug 06Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Jul 26Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Jul 12Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 21Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 10Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00
Mar 12Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00
Feb 27業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 3/31/2027 | 35,264 | 4,900 | -1,109 | 2,913 | 1 |
| 3/31/2026 | 32,393 | 4,240 | -2,103 | 1,919 | 1 |
| 3/31/2025 | 29,328 | 3,292 | -10,240 | 341 | 1 |
| 9/30/2024 | 27,074 | 3,896 | -11,724 | 1,650 | N/A |
| 6/30/2024 | 26,195 | 4,280 | N/A | N/A | N/A |
| 3/31/2024 | 26,450 | 5,531 | -6,498 | 2,106 | N/A |
| 12/31/2023 | 26,703 | 5,503 | N/A | N/A | N/A |
| 9/30/2023 | 26,626 | 4,607 | -4,074 | 1,899 | N/A |
| 6/30/2023 | 26,848 | 5,489 | N/A | N/A | N/A |
| 3/31/2023 | 25,090 | 6,060 | -950 | 4,004 | N/A |
| 12/31/2022 | 21,173 | 6,231 | N/A | N/A | N/A |
| 9/30/2022 | 20,135 | 8,043 | 4,382 | 7,170 | N/A |
| 6/30/2022 | 18,753 | 7,245 | N/A | N/A | N/A |
| 3/31/2022 | 17,748 | 7,127 | 4,339 | 5,952 | N/A |
| 12/31/2021 | 17,636 | 7,432 | N/A | N/A | N/A |
| 9/30/2021 | 16,068 | 6,025 | 4,075 | 5,301 | N/A |
| 6/30/2021 | 14,978 | 4,844 | N/A | N/A | N/A |
| 3/31/2021 | 15,110 | 3,661 | 3,629 | 4,746 | N/A |
| 12/31/2020 | 14,910 | 2,421 | N/A | N/A | N/A |
| 9/30/2020 | 15,175 | 2,812 | 1,389 | 2,706 | N/A |
| 6/30/2020 | 15,004 | 3,234 | N/A | N/A | N/A |
| 3/31/2020 | 14,561 | 2,550 | 1,788 | 3,018 | N/A |
| 12/31/2019 | 13,497 | 1,990 | N/A | N/A | N/A |
| 9/30/2019 | 13,167 | 1,915 | 1,784 | 2,988 | N/A |
| 6/30/2019 | 14,676 | 1,524 | N/A | N/A | N/A |
| 3/31/2019 | 15,658 | 1,950 | 1,794 | 2,892 | N/A |
| 12/31/2018 | 17,337 | -49 | N/A | N/A | N/A |
| 9/30/2018 | 17,928 | -993 | 1,631 | 2,943 | N/A |
| 6/30/2018 | 16,937 | -2,566 | N/A | N/A | N/A |
| 3/31/2018 | 16,600 | -3,555 | N/A | 1,344 | N/A |
| 12/31/2017 | 17,186 | -1,072 | N/A | N/A | N/A |
| 9/30/2017 | 17,714 | 327 | N/A | 280 | N/A |
| 6/30/2017 | 17,230 | 260 | N/A | N/A | N/A |
| 3/31/2017 | 17,244 | -915 | N/A | -849 | N/A |
| 12/31/2016 | 15,880 | -1,821 | N/A | N/A | N/A |
| 9/30/2016 | 15,269 | -1,273 | N/A | -3,109 | N/A |
| 6/30/2016 | 14,922 | -1,475 | N/A | N/A | N/A |
| 3/31/2016 | 14,750 | 2,646 | N/A | -3,339 | N/A |
| 12/31/2015 | 15,637 | 2,060 | N/A | N/A | N/A |
| 9/30/2015 | 16,344 | 401 | N/A | -2,379 | N/A |
| 6/30/2015 | 17,164 | 1,546 | N/A | N/A | N/A |
| 3/31/2015 | 17,835 | -1,385 | N/A | -2,156 | N/A |
| 12/31/2014 | 18,058 | -417 | N/A | N/A | N/A |
| 9/30/2014 | 17,161 | -599 | N/A | -1,377 | N/A |
| 6/30/2014 | 17,132 | -1,074 | N/A | N/A | N/A |
| 3/31/2014 | 16,926 | -754 | N/A | -1,620 | N/A |
| 12/31/2013 | 16,993 | -1,443 | N/A | N/A | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: 2395の予測収益成長率 (年間9.7% ) は 貯蓄率 ( 0.3% ) を上回っています。
収益対市場: 2395の収益 ( 9.7% ) はJP市場 ( 7.9% ) よりも速いペースで成長すると予測されています。
高成長収益: 2395の収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: 2395の収益 ( 7.3% ) JP市場 ( 4.2% ) よりも速いペースで成長すると予測されています。
高い収益成長: 2395の収益 ( 7.3% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: 2395の 自己資本利益率 は、3年後には低くなると予測されています ( 12.1 %)。